Skip to main content
Glama

Ebird

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool readOnly, idempotent, and non-destructive; the description adds valuable behavioral detail: graceful degradation when GLEIF/OpenFIGI are unavailable, explicit unresolved identifier reporting, multi-source cascading, and no over-assertion for ambiguous matches. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is front-loaded with usage examples and organized by supported type and behavior. Some nested parentheticals make parsing harder, but the detail is justified for a multi-source resolution tool with no output schema.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden and largely succeeds: it explains returned identifier types, source labeling, unresolved values, ambiguity handling via figi_candidates, and graceful degradation. Edge cases like non-equity instruments and non-US issuers are covered.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3, but the description and value parameter guidance add substantial meaning: exact input formatting rules, the 'ENTITY NAME ONLY' warning, issuer-name examples, trailing security-class word caveats, and accepted input forms beyond what the schema enumerates.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: resolve user-spoken names to canonical IDs (CIK, LEI, FIGI, RxCUI) for company and drug entities. Concrete example phrases and the 'Use FIRST' directive distinguish it from sibling lookup, search, and profile tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives explicit trigger phrases and the rule 'Use FIRST whenever you have a name but need an ID.' It does not enumerate explicit when-not-to-use cases or compare against sibling alternatives like entity_profile, but the intended context is clear enough.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Ebird toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation3/5

Several tools are close cousins: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all route to the same underlying data catalog, and bet_research/polymarket_edges/polymarket_arbitrage share a betting-research niche. The eBird tools are clearly a different cluster, but the server carries so many unrelated domains that an agent may struggle to pick the right category member (e.g., stable router vs beta router vs grounded router).

Naming Consistency3/5

Almost everything is snake_case, but the pattern is not uniform: there are plenty of verb_noun names (find_species, list_subregions, scan_competitor_ai_presence) mixed with bare consumer-style names (ask_pipeworx, bet_research, entity_profile, deep_research) and short helpers (recall, forget, remember). No mixed scripting-case chaos, but no consistent verb_noun or noun_verb system either.

Tool Count2/5

36 tools is heavy for a server that calls itself Ebird: only ~5 tools actually relate to bird observation, while the rest span Pipeworx data lookups, Polymarket betting, legal/regulatory analyzers, memory, subscriptions, competency scanning, npm package checking, and llms.txt generation. The count would be reasonable for a broad data platform, but the server's stated identity and the bundled tool set do not match, making the scope feel bloated and incoherent.

Completeness2/5

For a bird-centric server, the surface is thin: you can find a species, list subregions, and pull recent/notable observations, but you cannot get coordinated eBird atlases, hotspot details, species life-history stats, or region-based species lists. For the larger set of unrelated tools, completeness is impossible to gauge about a missing domain; the eBird purpose feels unfinished even though the miscellaneous tools are overloaded.

Resources